Australian-led mRNA cancer vaccine trial cuts melanoma return risk by 42 per cent

Australian scientists are leading a breakthrough in a world-first cancer vaccine, which has shown signs of drastically reducing the risk of melanoma coming back after surgery.

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.themercury.com.au)